AnalystsInsight

Tara Bancroft (TD Cowen): Analyst Track Record and Price‑Target Accuracy

How often Tara Bancroft’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 505 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#636 rank (was #484)+1 new rating (RCUS)+1 stock newly covered

Key takeaways

  • Tara Bancroft ranks #605 of 1,000 analysts in Exent’s scoring (4.8★).
  • 48.9% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 124 days; 42.3% of calls were up 12 months later.
  • Most‑covered stocks: URGN, OCUL, IRON, LNTH.
  • Free on Exent: Tara Bancroft’s full record, with ratings 3 days after publication.

Tara Bancroft’s track record at a glance

Tara Bancroft of TD Cowen ranks #605 of the 1,000 analysts Exent scores, with a 4.8★ rating and a focus on healthcare. Over a 7‑year lookback, 48.9% of Tara’s price targets were reached, 3.5 points below the 52.4% average across all analysts.

MetricTara BancroftAll analysts
Price‑target hit rate48.9%52.4%
Median days to hit target124 days91 days
Calls up after 12 months42.3%64.0%
Median 12‑month return of calls−17.2%+13.4%
Hit rate, last 2 years46.9%—
Average worst drop after a call−34.0%—
Ratings in the sample505—
Stocks covered25—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetTara Bancroft
Under 30 days13.5%
30–90 days19.8%
90–180 days27.0%
Over 180 days39.6%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Tara Bancroft covers most

StockRatings in the sample
URGN37
OCUL33
IRON33
LNTH27
GERN25
ASX-TLX24
CELC22
WHWK22

In the past year Tara’s ratings were 84% Buy, 16% Hold and 0% Sell.

Tara Bancroft’s latest ratings

DateStockActionRatingPrice target
Sep 16, 2026RCUSInitiated Coverage: BuyBuy$0.00
Sep 9, 2026FTHInitiated Coverage: BuyBuy$0.00
Sep 2, 2026EYPTDowngraded: HoldHold$4.00
Aug 13, 2026MGNXReiterated: HoldHold$0.00
Aug 13, 2026FATEReiterated: HoldHold$0.00
Aug 13, 2026CELCReiterated: BuyBuy$0.00
Aug 12, 2026STROReiterated: BuyBuy$0.00
Aug 12, 2026TCRXReiterated: BuyBuy$0.00
Aug 11, 2026VALNInitiated Coverage: BuyBuy$12.00
Aug 10, 2026RCKTReiterated: HoldHold$0.00
Aug 6, 2026WHWKReiterated: HoldHold$0.00
Aug 5, 2026XNCRReiterated: BuyBuy$0.00
  • Sep 16, 2026
    Stock
    RCUS
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $0.00
  • Sep 9, 2026
    Stock
    FTH
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $0.00
  • Sep 2, 2026
    Stock
    EYPT
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $4.00
  • Aug 13, 2026
    Stock
    MGNX
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Aug 13, 2026
    Stock
    FATE
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Aug 13, 2026
    Stock
    CELC
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Aug 12, 2026
    Stock
    STRO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Aug 12, 2026
    Stock
    TCRX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Aug 11, 2026
    Stock
    VALN
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $12.00
  • Aug 10, 2026
    Stock
    RCKT
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Aug 6, 2026
    Stock
    WHWK
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $0.00
  • Aug 5, 2026
    Stock
    XNCR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00

Tara’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Tara Bancroft’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Tara Bancroft ranks #605 of 1,000 with a 4.8★ rating. 48.9% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 42.3% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Tara Bancroft’s success rate is 46.3% by the ranking source and 48.9% by Exent’s price-target hit-rate backtest, with a median of 124 days to reach a target.

Tara Bancroft (TD Cowen) covers 25 stocks, mostly in healthcare. The most frequently rated are URGN, OCUL, IRON, LNTH, GERN.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.